NIH / NCATS SBIR & STTR — AI Drug Discovery
NIH / National Center for Advancing Translational Sciences
HIGH
T4
Startup
Strategy Notes
AI/ML drug discovery is an explicit NCATS priority area. Phase I ~$270K, Phase II ~$2M. Investigate international applicant eligibility — some mechanisms allow non-US entities with US collaboration. Strong strategic fit for resistance prediction.
Key Materials
NIH application (Specific Aims + Research Strategy + Budget), US entity or collaboration agreement, PI biosketch
Gate / Eligibility
US entity or US collaborator typically required at Phase I. Check NCATS international applicant policy. May need US co-PI or subsidiary.